| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-94 |
Sentence |
denotes |
The fibrinogen gamma 10034C>T polymorphism is not associated with Peripheral Arterial Disease. |
| T2 |
95-216 |
Sentence |
denotes |
Conversion of fibrinogen to fibrin plays an essential role in hemostasis and results in stabilization of the fibrin clot. |
| T3 |
217-391 |
Sentence |
denotes |
Fibrinogen consists of three pairs of non-identical polypeptide chains, encoded by different genes (fibrinogen alpha [FGA], fibrinogen beta [FGB] and fibrinogen gamma [FGG]). |
| T4 |
392-588 |
Sentence |
denotes |
A functional single nucleotide polymorphism (SNP) in the 3' untranslated region of the FGG gene (FGG 10034C>T, rs2066865) has been associated with deep venous thrombosis and myocardial infarction. |
| T5 |
589-696 |
Sentence |
denotes |
Aim of the present study was to analyze the role of this polymorphism in peripheral arterial disease (PAD). |
| T6 |
697-810 |
Sentence |
denotes |
The study was designed as case-control study including 891 patients with documented PAD and 777 control subjects. |
| T7 |
811-872 |
Sentence |
denotes |
FGG genotypes were determined by exonuclease (TaqMan) assays. |
| T8 |
873-956 |
Sentence |
denotes |
FGG genotype frequencies were not significantly different between PAD patients (CC: |
| T9 |
957-967 |
Sentence |
denotes |
57.3%, CT: |
| T10 |
968-978 |
Sentence |
denotes |
36.7%, TT: |
| T11 |
979-1010 |
Sentence |
denotes |
5.8%) and control subjects (CC: |
| T12 |
1011-1021 |
Sentence |
denotes |
60.9%, CT: |
| T13 |
1022-1046 |
Sentence |
denotes |
33.5%, TT 5.6%; p=0.35). |
| T14 |
1047-1328 |
Sentence |
denotes |
In a multivariate logistic regression analysis including age, sex, smoking, diabetes, arterial hypertension and hypercholesterolemia, the FGG 10034 T variant was not significantly associated with the presence of PAD (Odds ratio 1.07, 95% confidence interval 0.84 - 1.37; p = 0.60). |
| T15 |
1329-1415 |
Sentence |
denotes |
The FGG 10034C>T polymorphism was furthermore not associated with age at onset of PAD. |
| T16 |
1416-1533 |
Sentence |
denotes |
We conclude that the thrombophilic FGG 10034 T gene variant does not contribute to the genetic susceptibility to PAD. |